Le fait de fermer ne sauvegardera pas votre configuration à moins que vous n'ajoutiez l'article à votre Panier d'achat ou à vos Favoris.
Cliquer sur OK pour fermer l'outil MILLIPLEX® MAP ou sur Annuler pour retourner à votre sélection.
Choisissez des Panels configurables & des Kits préconfigurés - OU - des MAPmate™ de signalisation cellulaire
Concevez vos kits MILLIPLEX® MAP et obtenez leur prix.
Panels configurables & Kits préconfigurés
Notre large gamme est constituée de panels multiplex qui vous permettent de choisir, au sein d'un panel, les analytes qui répondent le mieux à vos besoins. Sur un autre onglet, vous pouvez choisir un format cytokine préconfiguré ou un kit Simplex.
Kits de signalisation cellulaire & MAPmate™
Choisissez des kits préconfigurés qui permettent d'explorer l'ensemble des voies ou des processus. Ou concevez vos propres kits en choisissant des Simplex MAPmate™ et en suivant les instructions fournies.
Les MAPmate™ suivants ne peuvent pas être utilisés ensemble : -des MAPmate™ qui nécessitent des tampons différents -des paires de MAPmate™ totaux et phospho-spécifiques, par ex. GSK3β total et GSK3β (Ser 9) -des MAPmate™ PanTyr et spécifiques d'un site, par ex. Récepteur Phospho-EGF et phospho-STAT1 (Tyr701) -Plus d'un phospho-MAPmate™ pour une seule cible (Akt, STAT3). -GAPDH et β-Tubuline ne peuvent pas être utilisés avec les kits ou les MAPmate™ contenant panTyr.
.
Référence
Guide d'achat
Qté
Liste
Cet article a été ajouté à vos favoris.
Sélectionner une espèce, un type de panel, un kit ou un type d'échantillon
Pour commencer à concevoir votre kit MILLIPLEX® MAP, sélectionnez une espèce, un type de panel ou un kit d'intérêt.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Cet article a été ajouté à vos favoris.
Espèce
Type de panel
Kit sélectionné
Qté
Référence
Guide d'achat
Qté
Prix tarif
96-Well Plate
Qté
Référence
Guide d'achat
Qté
Prix tarif
Ajouter des réactifs supplémentaires (Un kit "Buffer and Detection Kit" est nécessaire pour une utilisation avec les MAPmate™)
Qté
Référence
Guide d'achat
Qté
Prix tarif
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Option de gain de place Nos clients qui commandent plusieurs kits peuvent choisir d'économiser de l'espace de stockage en éliminant l'emballage de chaque kit et de recevoir les composants de leur essai multiplex conditionnés sous poches en plastique pour un stockage plus compact.
Cet article a été ajouté à vos favoris.
Ce produit a été ajouté à votre panier.
Vous pouvez maintenant concevoir un autre kit personnalisé, choisir un kit pré-configuré, régler vos achats ou fermer l'outil de commande.
OP29L
Sigma-AldrichAnti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240)
This Anti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240) is validated for use in FC, Frozen Sections, Gel Shift, Immunoblotting, IF, IP, Paraffin Sections for the detection of p53 (Ab-3) (Mutant).
More>>This Anti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240) is validated for use in FC, Frozen Sections, Gel Shift, Immunoblotting, IF, IP, Paraffin Sections for the detection of p53 (Ab-3) (Mutant). Less<<
Anti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240) : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Le champ quantité est vide. Veuillez saisir une quantité supérieure ou égale à 1 au minimum pour ajouter des articles à votre panier.
Description
Overview
Recognizes the ~53 kDa mutant p53 protein under non-denaturing conditions by immunoprecipitation, immunofluorescence, and flow cytometry. Recognizes both mutant and wild-type p53 by immunoblotting and paraffin sections under denaturing conditions.
Catalogue Number
OP29L
Brand Family
Calbiochem®
References
References
El-Deiry, W.S., et al. 1994. Cancer Res.54, 1169. Greenblatt, M.S., et al. 1994. Cancer Res.54, 4855. Barak, Y., et al. 1993. EMBO J.12, 461. Kastan, M.B., et al. 1992. Cell71, 587. Kuerbitz, S.J. 1992. Proc. Natl. Acad. Sci. USA89, 7491. Lane, D.P. 1992. Nature358, 15. Kastan, M.B., et al. 1991. Cancer Res.51, 6304.
Product Information
Form
Lyophilized
Formulation
Lyophilized from a volatile buffer, 100 µg BSA.
Negative control
SK-OV-3 cells
Positive control
A431, Hs27 (wild-type p53), or SK-BR-3 cells or breast carcinoma
Flow Cytometry (1-20 µg/ml) Frozen Sections (10 µg/ml) Gel Shift (see comments) Immunoblotting (5 µg/ml) Immunofluorescence (1-20 µg/ml) Immunoprecipitation (1 µg per sample) Paraffin Sections (see application references)
Application Comments
Under non-denaturing conditions (immunoprecipitation, immunofluorescence and frozen sections), p53 (Ab-3) does not bind to normal (wild-type) p53 protein; it recognizes an epitope exposed by activating mutations or denaturation. In denaturing protocols (immunoblotting and paraffin sections), p53 (Ab-3) will recognize both mutant and wild-type p53. Will not recognize to some p53 molecules with mutations in the RHSVV epitope, but will recognize TFIIIA, which has the RHSVV epitope. For gel shift assay, resuspend in 100 µl buffer. Antibodies should be titrated for optimal results in individual systems.
Biological Information
Immunogen
a recombinant protein consisting of amino acids 14-389 of p53 fused to β-galactosidase
Immunogen
Human
Epitope
within amino acids 213-217
Clone
PAb240
Host
Mouse
Isotype
IgG₁
Species Reactivity
Bovine
Chicken
Hamster
Human
Mouse
Rat
Antibody Type
Monoclonal Antibody
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code
Ambient Temperature Only
Toxicity
Standard Handling
Storage
+2°C to +8°C
Do not freeze
Ok to freeze
Special Instructions
Reconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
Revision
26-February-2008 JSW
Application
Flow Cytometry (1-20 µg/ml) Frozen Sections (10 µg/ml) Gel Shift (see comments) Immunoblotting (5 µg/ml) Immunofluorescence (1-20 µg/ml) Immunoprecipitation (1 µg per sample) Paraffin Sections (see application references)
Description
Purified mouse monoclonal antibody generated by immunizing BALB/c mice with the specified immunogen and fusing of splenocytes with SP2 mouse myeloma cells (see application references). Recognizes the ~53 kDa mutant p53 protein under non-denaturing conditions and both mutant and wild-type p53 under denaturing conditions.
Background
The human p53 tumor suppressor gene encodes a 393 amino acid phosphoprotein that exhibits sequence-specific DNA binding and directly interacts with various cellular and viral proteins. p53 is the most commonly mutated gene in human cancer, with the majority of the mutations being amino acid substitutions. The normal function of p53 is to effect cell cycle arrest at the G1 and G2 checkpoints in response to DNA damage. This checkpoint function is executed by accumulation of p53 followed by induction of the GADD45, WAF1 and MDM2 genes. The current model of p53 function postulates that p53 senses DNA damage and arrests the cell cycle in either the G1 or G2 phases to allow DNA repair to take place. If repair is not successful, p53 initiates programmed cell death, thus preventing the propagation of genetic defects to successive generations of cells.
Host
Mouse
Immunogen species
Human
Immunogen
a recombinant protein consisting of amino acids 14-389 of p53 fused to β-galactosidase
Epitope
within amino acids 213-217
Clone
PAb240
Isotype
IgG₁
Species
not Xenopus, bovine, chicken, hamster, human, mouse, rat
Positive control
A431, Hs27 (wild-type p53), or SK-BR-3 cells or breast carcinoma
Negative control
SK-OV-3 cells
Form
Lyophilized
Formulation
Lyophilized from a volatile buffer, 100 µg BSA.
Preservative
None
Comments
Under non-denaturing conditions (immunoprecipitation, immunofluorescence and frozen sections), p53 (Ab-3) does not bind to normal (wild-type) p53 protein; it recognizes an epitope exposed by activating mutations or denaturation. In denaturing protocols (immunoblotting and paraffin sections), p53 (Ab-3) will recognize both mutant and wild-type p53. Will not recognize to some p53 molecules with mutations in the RHSVV epitope, but will recognize TFIIIA, which has the RHSVV epitope. For gel shift assay, resuspend in 100 µl buffer. Antibodies should be titrated for optimal results in individual systems.
Storage
+2°C to +8°C
Do Not Freeze
Ok to freeze
Special Instructions
Reconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide
Toxicity
Standard Handling
References
El-Deiry, W.S., et al. 1994. Cancer Res.54, 1169. Greenblatt, M.S., et al. 1994. Cancer Res.54, 4855. Barak, Y., et al. 1993. EMBO J.12, 461. Kastan, M.B., et al. 1992. Cell71, 587. Kuerbitz, S.J. 1992. Proc. Natl. Acad. Sci. USA89, 7491. Lane, D.P. 1992. Nature358, 15. Kastan, M.B., et al. 1991. Cancer Res.51, 6304.
Application references
Paraffin Sections
Pezzella, F., et al. 1994. J. Clin. Pathol.47, 592.
Original Clone
Gannon, J.V., et al. 1990. EMBO J.9, 1595.
Epitope Identification
Stephen, C.W. and Lane, D.P., 1992. J. Mol. Biol.225, 1.
Immunofluorescence
Bernardi, R., et al. 2004. Nat. Cell Biol.6, 665.